Tepnel Pharma Services
Abstract: Tepnel Pharma Services is an independent UK contract GMP quality control testing laboratory for the analytical testing of both developmental and market authorised pharmaceuticals. From our MHRA and FDA inspected facilities in Scotland we provide analytical support for UK, EU and global batch release activities, ICH Stability testing, compendial analysis in support of manufacturing and analytical methods development and validation. With a focus on tablets, capsules, parenteral, inhalation formulations and complex peptides, Tepnel draws on >30 years of experience servicing global pharmaceutical companies. Tepnel people are committed to providing laboratory services that deliver on the promise of affordability, adaptability and accountability with a strong outcome focussed culture and an emphasis on working collaboratively with our partners through a Vested Outsourcing approach we encourage you to let go of the things that you can’t change and focus on the things that you can.
Description: Tepnel Pharma Services is the outsourcing brand of Hologic Ltd., a global healthcare company. Based in Livingston, Scotland and Manchester, England the Tepnel brand is a respected and globally recognised provider of contract GMP quality control testing. We focus on services that support the development of new pharmaceutical products and the routine manufacturing and release of market authorised final pharmaceutical preparations.
We provide stability storage for all key ICH climatic zones. Our available conditions and storage solutions are suitable for long term, intermediate, accelerated, photo-stability, in-use and FUST stability trials.
At Tepnel we focus on delivering a specific set of services in a manner that unlocks greater value for both our customers and ourselves. Through the use of the Vested outsourcing philosophy and lean manufacturing tools, we seek to eliminate waste through innovating the way in which we manage your ICH Stability testing.
By value Stream mapping of the processes, including upstream and downstream activity, we are able to offer our customers additional economic value, which results in reduced outsourcing cost to the Contract Giver and increased efficiency and speed, reporting data earlier whilst maintaining compliance.
The advantages of our approach to outsourcing provides our partners with:
- Zero cost at T(0) on all ICH stability programmes.
- Up to 50% cost saving on full stability management of your product portfolio.
- Process innovation that results in approximately 35% reduction in turnaround times.
- A management approach to L2L method transfer which is based on reciprocity and which takes away the risk of changing from your current supplier.
Category: Business Process
Type: Small Molecules
Contact: David Scott, Dr Vikki Renwick ([email protected] , [email protected])